title: [Cell grafts: current and perspectives. II. Cells and transformation procedure challenge and future].
abstract: All medical doctors are concerned by the medical scientific, ethical, economic and reglementary aspects of cells transplantation. However, hematopoietic stem cells are the most used cells in transplantation in case of leukemia, and solid tumor. Other human or animal cells are used to graft burned patients, patients with severe liver failure, knee traumatism and other exceptional disease. Autologous expanded keratinocytes, chondrocytes, hepatocytes are sometime transplanted. Most cellular products are processed before being transplanted. These processes, more or less complicated, use physical, immunological and functional characteristics of the cells. Most cellular products are processed by non profit organisms as said by the "94 bioethic law".
authors.forename: G
authors.initials: G
authors.lastname: Novakovitch
mesh_terms: D002461:Cell Line, Transformed; D017690:Cell Transplantation / Q000639:trends*; D005544:Forecasting; D018380:Hematopoietic Stem Cell Transplantation / Q000639:trends; D006801:Humans; D008099:Liver / Q000166:cytology; D012867:Skin / Q000166:cytology
vernacular_title: Les greffes de cellules: actualité et perspectives. II. Cellules et procédés de transformations: enjeu et avenir.